New pill shows promise for cutting binge eating days
NCT ID NCT05113953
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study tested a new medication called centanafadine in 147 adults with moderate to severe binge eating disorder. Participants took either a low dose, a high dose, or a placebo pill daily for several weeks. The main goal was to see if the drug could reduce the number of days per week with binge eating episodes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BINGE-EATING DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ActivMed Practices and Research - Portsmouth
Portsmouth, New Hampshire, 03801, United States
-
Boston Clinical Trials
Boston, Massachusetts, 02131, United States
-
Center for Emotional Fitness
Cherry Hill, New Jersey, 08002, United States
-
Clinical Neuroscience Solutions - Jacksonville
Jacksonville, Florida, 32256, United States
-
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, 38119, United States
-
Collaborative Neuroscience Research, LLC
Garden Grove, California, 92845, United States
-
Collective Medical Research
Prairie Village, Kansas, 66208, United States
-
Craig and Frances Linder Center of Hope
Mason, Ohio, 45040, United States
-
FutureSearch Trials - Dallas
Dallas, Texas, 75231, United States
-
Manhattan Behavioral Medicine
New York, New York, 10036, United States
-
Medical Research Network, LLC
New York, New York, 10128, United States
-
Miami Dade Medical Research Institute
Miami, Florida, 33176, United States
-
Midwest Clinical Research Center
Dayton, Ohio, 45417, United States
-
Mountain View Clinical Research, LLC
Denver, Colorado, 80209, United States
-
NoesisPharma, LLC
Phoenix, Arizona, 85016, United States
-
Pacific Clinical Research Management Group LLC
Upland, California, 91786, United States
-
Pharmacology Research Institute - San Fernando Valley
Encino, California, 91316, United States
-
Princeton Medical Institute
Princeton, New Jersey, 08540, United States
-
Psych Atlanta, PC
Marietta, Georgia, 30060, United States
-
Psychiatric Associates
Overland Park, Kansas, 66211, United States
-
Psychiatry + Psychotherapy Partners Austin
Austin, Texas, 78737, United States
-
Richmond Behavioral Associates
Staten Island, New York, 10312, United States
-
Southern California Research LLC
Beverly Hills, California, 90210, United States
-
St. Charles Psychiatric Associates & Midwest Research Group
Weldon Spring, Missouri, 63304, United States
-
iResearch Atlanta
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.